TD SYNNEX director Dennis Polk sells 3,955 shares

Q: How many SNX shares did Dennis Polk sell, and at what price?

Dennis Polk sold 3,955 common shares on October 21, 2026, at a weighted average price of $251.27 per share. Reported sale prices ranged from $251.25 to $251.31, and no Rule 10b5-1 plan is reported for the sale.

Q: How many shares did Dennis Polk acquire through SNX option exercises?

On October 21, 2026, he exercised options covering 1,050 common shares at $106.35 per share and 2,905 common shares at $107.32 per share.

Q: How do the SNX options vest?

The options vest as to 20% of the shares on the first anniversary of the grant date, then as to 1/60th of the shares monthly thereafter.

The options vest 20% on the first anniversary of the grant date and 1/60th of the shares monthly thereafter.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

TD SYNNEX Corp. director and officer Dennis Polk, whose title is Chair, Hyve Solutions, exercised options covering 1,050 common shares at $106.35 per share and 2,905 common shares at $107.32 per share on October 21, 2026. He sold 3,955 common shares that day at a weighted average price of $251.27 per share; reported sale prices ranged from $251.25 to $251.31. Afterward, the reported option positions were 611 Stock Option shares and 0 Employee Stock Option shares. Separately, 66,647 common shares were held indirectly through a trust.

Insider Trade Summary

Exercise and Sale: 3,955 shares ($570K approx. pre-tax spread)

Exercise and Sale 6 txns

Insider POLK DENNIS

Role Chair, Hyve Solutions

Sold 3,955 shs ($994K)

Approx. gross sale proceeds $994K

Approx. exercise cost $423K

Approx. pre-tax spread $570K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) ^F2	1,050	$0.00	$0.00
Exercise	Employee Stock Option (Right to Buy) ^F2	2,905	$0.00	$0.00
Exercise	Common Stock	1,050	$106.35	$112K
Exercise	Common Stock	2,905	$107.32	$312K
Sale	Common Stock ^F1	3,955	$251.27	$994K
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 611 contracts (Direct); Employee Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 20,550 shares (Direct); Common Stock — 66,647 shares (Indirect, By Trust)

Footnotes (2)

F1. Represents the weighted average sales price for a number of transactions effected at prices ranging from $251.25 to $251.31. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
F2. This stock option vests as to 20% of the shares on the first anniversary of the date of grant and vests as to 1/60th of the shares monthly thereafter.

Key Figures

Stock Option exercise: 1,050 common shares at $106.35 per share Employee Stock Option exercise: 2,905 common shares at $107.32 per share Common shares sold: 3,955 shares +4 more

7 metrics

Stock Option exercise 1,050 common shares at $106.35 per share October 21, 2026

Employee Stock Option exercise 2,905 common shares at $107.32 per share October 21, 2026

Common shares sold 3,955 shares October 21, 2026

Weighted average sale price $251.27 per share October 21, 2026

Reported sale price range $251.25–$251.31 per share Prices for the reported sale transactions

Option positions after exercise 611 Stock Option shares; 0 Employee Stock Option shares Following the October 21, 2026 transactions

Common shares held indirectly through a trust 66,647 shares Reported holding

Key Terms

weighted average sales price, Stock Option (Right to Buy), vests as to 1/60th

3 terms

weighted average sales price financial

"weighted average sales price for a number of transactions"

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

vests as to 1/60th financial

"vests as to 1/60th of the shares monthly thereafter"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SNX shares did Dennis Polk sell, and at what price?

Dennis Polk sold 3,955 common shares on October 21, 2026, at a weighted average price of $251.27 per share. Reported sale prices ranged from $251.25 to $251.31, and no Rule 10b5-1 plan is reported for the sale.

How many shares did Dennis Polk acquire through SNX option exercises?

On October 21, 2026, he exercised options covering 1,050 common shares at $106.35 per share and 2,905 common shares at $107.32 per share.

How do the SNX options vest?

The options vest as to 20% of the shares on the first anniversary of the grant date, then as to 1/60th of the shares monthly thereafter.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/22/2026 - 04:17 PM EDT Accepted by SEC EDGAR 10/22/2026 - 04:17 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POLK DENNIS

(Last)

(First)

(Middle)

C/O TD SYNNEX CORPORATION

16202 BAY VISTA DRIVE

(Street)

CLEARWATER

FLORIDA

33760

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chair, Hyve Solutions

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/21/2026		M		1,050	A	$106.35	21,600	D
Common Stock	10/21/2026		M		2,905	A	$107.32	24,505	D
Common Stock	10/21/2026		S		3,955	D	$251.27⁽¹⁾	20,550	D
Common Stock								66,647	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$106.35	10/21/2026		M			1,050	⁽²⁾	01/19/2032	Common Stock	1,050	$0	611	D
Employee Stock Option (Right to Buy)	$107.32	10/21/2026		M			2,905	⁽²⁾	10/05/2031	Common Stock	2,905	$0	0	D

Explanation of Responses:

1. Represents the weighted average sales price for a number of transactions effected at prices ranging from $251.25 to $251.31. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.

2. This stock option vests as to 20% of the shares on the first anniversary of the date of grant and vests as to 1/60th of the shares monthly thereafter.

Remarks:

	/s/ Cheryl Grant, attorney-in-fact	10/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR